Company Filing History:
2 out of 123 
2 out of 263 Years Active: 2023-2024
Title: Innovator Spotlight: Jonas Calleja Priede
Introduction
Jonas Calleja Priede is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biomedical research, with a focus on isoindolinone derivatives and their potential applications in cancer therapy. With two patents to his name, his work highlights the innovative processes for preparing complex chemical compounds that can inhibit crucial oncogenic interactions.
Latest Patents
Jonas’s latest patents include compelling research titled "Isoindolinone Inhibitors of the MDM2-P53 Interaction and Process for Making Them." This invention delves into the processes for preparing isoindolin-1-one derivatives. It particularly focuses on the synthesis of the compound (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid, alongside its crystalline forms and salts. This innovative approach aims to enhance therapeutic outcomes by targeting the MDM2-P53 interaction, a pivotal mechanism in tumor suppression.
Career Highlights
Jonas has an impressive career, contributing to extensive research during his tenure at renowned companies such as Astex Therapeutics Limited and Cancer Research Technology Limited. His work has been pivotal in developing new therapeutic strategies, further showcasing his commitment to advancing medical science.
Collaborations
Throughout his career, Jonas has collaborated with distinguished colleagues, including Steven Howard and Jeffrey David St Denis. These collaborations have fostered a rich environment for innovation, allowing him to leverage diverse expertise and develop groundbreaking inventions in the field of oncology.
Conclusion
Jonas Calleja Priede exemplifies the spirit of innovation through his work on isoindolinone derivatives. His patents are a testament to the ongoing fight against cancer and highlight the importance of collaborative efforts in scientific research. As he continues to contribute to this vital field, his inventions stand as significant strides toward improving patient outcomes.